Endocrine therapy in ovarian cancer: where do we stand?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynecology
Reference51 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Ovarian cancer;Hennessy;Lancet,2009
3. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Colombo;Ann Oncol,2010
4. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N Engl J Med,2011
5. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial;Oza;Lancet Oncol,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma;International Journal of Cancer;2024-01-11
2. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER;Life Sciences;2023-11
3. Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer;Frontiers in Oncology;2023-03-10
4. Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes;Frontiers in Oncology;2023-01-27
5. Metastasis prevention: targeting causes and roots;Clinical & Experimental Metastasis;2022-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3